Effects of hypoglycemic sulfonamides on glucagon and insulin secretion in ducks and dogs.
D000818:Animals; D000941:Antigens; D001158:Arteries; D001786:Blood Glucose; D002264:Carboxylic Acids / Q000008:administration & dosage / Q000494:pharmacology; D004285:Dogs; D004372:Ducks; D004987:Ethers / Q000008:administration & dosage / Q000494:pharmacology; D005263:Femoral Artery; D005934:Glucagon / Q000097:blood / Q000378:metabolism*; D005905:Glyburide / Q000008:administration & dosage / Q000494:pharmacology*; D007004:Hypoglycemic Agents / Q000494:pharmacology; D007275:Injections, Intravenous; D007328:Insulin / Q000097:blood / Q000378:metabolism*; D000078790:Insulin Secretion; D010179:Pancreas / Q000098:blood supply; D011743:Pyrimidines / Q000008:administration & dosage / Q000494:pharmacology*; D013045:Species Specificity; D013449:Sulfonamides / Q000008:administration & dosage / Q000494:pharmacology*; D014044:Tolbutamide / Q000008:administration & dosage / Q000494:pharmacology*; D014680:Veins
D000941:Antigens; D001786:Blood Glucose; D002264:Carboxylic Acids; D004987:Ethers; D007004:Hypoglycemic Agents; D007328:Insulin; D011743:Pyrimidines; D013449:Sulfonamides; D005934:Glucagon; D014044:Tolbutamide; D005905:Glyburide